NRx Pharmaceuticals to Participate in H.C. Wainwright Neuro Perspectives Conference

NRx Pharmaceuticals

RADNOR, PANRx Pharmaceuticals, Inc. (Nasdaq: NRXP) announced that its management team will participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024.

Dr. Jonathan Javitt, Chairman and Chief Scientist of NRx Pharmaceuticals, will engage in a fireside chat at 7:00 a.m. ET on June 27. Interested parties can access the discussion via a link on the company’s Investor Relations website. In addition, Dr. Javitt and Matthew Duffy, Chief Business Officer, will hold one-on-one meetings with investors throughout the day.

The H.C. Wainwright Neuro Perspectives Virtual Conference is a key event in the neuroscience sector. Scheduled for June 27, 2024, the conference features keynote speakers and company presentations, offering updates and insights into the latest developments in neuroscience. It also provides networking opportunities and private meetings between investors and executives.

Participants typically include public and private companies, industry executives, business development professionals, institutional investors, private equity firms, and venture capitalists.

NRx Pharmaceuticals’ involvement aims to showcase the company’s cutting-edge research and development in neurological disorders.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.

READ:  Lincoln Financial Group to Announce Q2 2024 Results